596 related articles for article (PubMed ID: 28637869)
61. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.
Fehrholz M; Kendl S; Prifert C; Weissbrich B; Lemon K; Rennick L; Duprex PW; Rima BK; Koning FA; Holmes RK; Malim MH; Schneider-Schaulies J
J Gen Virol; 2012 Mar; 93(Pt 3):565-576. PubMed ID: 22170635
[TBL] [Abstract][Full Text] [Related]
62. AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation.
Diamond CP; Im J; Button EA; Huebert DNG; King JJ; Borzooee F; Abdouni HS; Bacque L; McCarthy E; Fifield H; Berghuis LM; Larijani M
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129415. PubMed ID: 31404619
[TBL] [Abstract][Full Text] [Related]
63. Dual effect of APOBEC3G on Hepatitis B virus.
Noguchi C; Hiraga N; Mori N; Tsuge M; Imamura M; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Yatsuji H; Shirakawa K; Takaori-Kondo A; Chayama K
J Gen Virol; 2007 Feb; 88(Pt 2):432-440. PubMed ID: 17251560
[TBL] [Abstract][Full Text] [Related]
64. Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.
Kanagaraj A; Sakamoto N; Que L; Li Y; Mohiuddin M; Koura M; Wakae K; Kurachi M; Muramatsu M; Kitamura K
Biochem Biophys Res Commun; 2019 Oct; 518(1):26-31. PubMed ID: 31400856
[TBL] [Abstract][Full Text] [Related]
65. Determinants of sequence-specificity within human AID and APOBEC3G.
Carpenter MA; Rajagurubandara E; Wijesinghe P; Bhagwat AS
DNA Repair (Amst); 2010 May; 9(5):579-87. PubMed ID: 20338830
[TBL] [Abstract][Full Text] [Related]
66. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
[TBL] [Abstract][Full Text] [Related]
67. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
Ajoge HO; Renner TM; Bélanger K; Greig M; Dankar S; Kohio HP; Coleman MD; Ndashimye E; Arts EJ; Langlois MA; Barr SD
Nat Commun; 2023 Jan; 14(1):16. PubMed ID: 36627271
[TBL] [Abstract][Full Text] [Related]
68. Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
Hou S; Silvas TV; Leidner F; Nalivaika EA; Matsuo H; Kurt Yilmaz N; Schiffer CA
J Chem Theory Comput; 2019 Jan; 15(1):637-647. PubMed ID: 30457868
[TBL] [Abstract][Full Text] [Related]
69. Hypoxia-Inducible Factor 1 Alpha-Mediated RelB/APOBEC3B Down-regulation Allows Hepatitis B Virus Persistence.
Riedl T; Faure-Dupuy S; Rolland M; Schuehle S; Hizir Z; Calderazzo S; Zhuang X; Wettengel J; Lopez MA; Barnault R; Mirakaj V; Prokosch S; Heide D; Leuchtenberger C; Schneider M; Heßling B; Stottmeier B; Wessbecher IM; Schirmacher P; McKeating JA; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwalder M
Hepatology; 2021 Oct; 74(4):1766-1781. PubMed ID: 33991110
[TBL] [Abstract][Full Text] [Related]
70. The C-terminal cytidine deaminase domain of APOBEC3G itself undergoes intersegmental transfer for a target search, as revealed by real-time NMR monitoring.
Kamba K; Nagata T; Katahira M
Phys Chem Chem Phys; 2018 Jan; 20(5):2976-2981. PubMed ID: 28905055
[TBL] [Abstract][Full Text] [Related]
71. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
Lucifora J; Xia Y; Reisinger F; Zhang K; Stadler D; Cheng X; Sprinzl MF; Koppensteiner H; Makowska Z; Volz T; Remouchamps C; Chou WM; Thasler WE; Hüser N; Durantel D; Liang TJ; Münk C; Heim MH; Browning JL; Dejardin E; Dandri M; Schindler M; Heikenwalder M; Protzer U
Science; 2014 Mar; 343(6176):1221-8. PubMed ID: 24557838
[TBL] [Abstract][Full Text] [Related]
72. Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander RJ; Csako G; Patterson AP
J Mol Biol; 2012 Apr; 418(1-2):65-81. PubMed ID: 22326345
[TBL] [Abstract][Full Text] [Related]
73. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
74. Long-term passage of Vif-null HIV-1 in CD4
Miyagi E; Kao S; Fumitaka M; Buckler-White A; Plishka R; Strebel K
Virology; 2017 Apr; 504():1-11. PubMed ID: 28131088
[TBL] [Abstract][Full Text] [Related]
75. Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.
Solomon WC; Myint W; Hou S; Kanai T; Tripathi R; Kurt Yilmaz N; Schiffer CA; Matsuo H
Nucleic Acids Res; 2019 Aug; 47(14):7676-7689. PubMed ID: 31424549
[TBL] [Abstract][Full Text] [Related]
76. APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
Cannataro VL; Kudalkar S; Dasari K; Gaffney SG; Lazowski HM; Jackson LK; Yildiz I; Das RK; Gould Rothberg BE; Anderson KS; Townsend JP
Lung Cancer; 2022 Sep; 171():34-41. PubMed ID: 35872531
[TBL] [Abstract][Full Text] [Related]
77. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
Nowarski R; Kotler M
Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
79. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
80. Human APOBEC1 cytidine deaminase edits HBV DNA.
Gonzalez MC; Suspène R; Henry M; Guétard D; Wain-Hobson S; Vartanian JP
Retrovirology; 2009 Oct; 6():96. PubMed ID: 19843348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
